160 related articles for article (PubMed ID: 31376222)
1. The clinical prognostic significance of ezrin in patients with bone and soft tissue sarcomas: a meta-analysis.
Wang F; Yu T; Ma C; Zhang H; Zhang Z
FEBS Open Bio; 2019 Oct; 9(10):1744-1755. PubMed ID: 31376222
[TBL] [Abstract][Full Text] [Related]
2. Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas.
Carneiro A; Bendahl PO; Åkerman M; Domanski HA; Rydholm A; Engellau J; Nilbert M
J Clin Pathol; 2011 Aug; 64(8):689-94. PubMed ID: 21653656
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis.
Li YJ; Dai YL; Zhang WB; Li SJ; Tu CQ
Clin Exp Med; 2017 Feb; 17(1):59-69. PubMed ID: 26678086
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of PD-L1 expression in sarcoma: A systematic review and meta-analysis.
Zheng C; You W; Wan P; Jiang X; Chen J; Zheng Y; Li W; Tan J; Zhang S
Medicine (Baltimore); 2018 Jun; 97(25):e11004. PubMed ID: 29923984
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Programmed Cell Death 1 Ligand-1 in Patients With Bone and Soft Tissue Sarcomas: A Systemic and Comprehensive Meta-Analysis Based on 3,680 Patients.
Wang F; Yu T; Ma C; Yuan H; Zhang H; Zhang Z
Front Oncol; 2020; 10():749. PubMed ID: 32582532
[No Abstract] [Full Text] [Related]
6. Prognostic Value of Ezrin in Various Cancers: A Systematic Review and Updated Meta-analysis.
Li J; Wei K; Yu H; Jin D; Wang G; Yu B
Sci Rep; 2015 Dec; 5():17903. PubMed ID: 26632332
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of Ezrin in solid tumors: a meta-analysis of the literature.
Han K; Qi W; Gan Z; Shen Z; Yao Y; Min D
PLoS One; 2013; 8(7):e68527. PubMed ID: 23894313
[TBL] [Abstract][Full Text] [Related]
8. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas.
Weng WH; Ahlén J; Aström K; Lui WO; Larsson C
Clin Cancer Res; 2005 Sep; 11(17):6198-204. PubMed ID: 16144921
[TBL] [Abstract][Full Text] [Related]
10. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis.
Li YJ; Dai YL; Cheng YS; Zhang WB; Tu CQ
Eur J Surg Oncol; 2016 Aug; 42(8):1103-14. PubMed ID: 27189833
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated E-cadherin expression is associated with poor five-year overall survival in bone and soft tissue sarcoma: results of a meta-analysis.
Wang N; He YL; Pang LJ; Zou H; Liu CX; Zhao J; Hu JM; Zhang WJ; Qi Y; Li F
PLoS One; 2015; 10(3):e0121448. PubMed ID: 25822802
[TBL] [Abstract][Full Text] [Related]
13. Ezrin and moesin expression in canine and feline osteosarcoma.
Hlavaty J; Wolfesberger B; Hauck M; Obermayer-Pietsch B; Fuchs-Baumgartinger A; Miller I; Walter I
Histol Histopathol; 2017 Aug; 32(8):805-816. PubMed ID: 27900754
[TBL] [Abstract][Full Text] [Related]
14. Prognosis value of Hypoxia-inducible factor-1α expression in patients with bone and soft tissue sarcoma: a meta-analysis.
Li Y; Zhang W; Li S; Tu C
Springerplus; 2016; 5(1):1370. PubMed ID: 27606158
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas.
Kuhnen C; Herter P; Müller O; Muehlberger T; Krause L; Homann H; Steinau HU; Müller KM
Mod Pathol; 2000 Sep; 13(9):1005-13. PubMed ID: 11007041
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of p16
Lin G; Lou Y
Indian J Cancer; 2017; 54(3):580-583. PubMed ID: 29798963
[TBL] [Abstract][Full Text] [Related]
17. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
18. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.
Li H; Min D; Zhao H; Wang Z; Qi W; Zheng S; Tang L; He A; Sun Y; Yao Y; Shen Z
PLoS One; 2013; 8(6):e64513. PubMed ID: 23805177
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
Li Y; Liu X; Zhang J; Yao W
Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
